Skip to main content
SpringerLink
Log in

The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases

  • Minireview
  • Published:
Molecules and Cells

Abstract

Members of the nuclear receptor superfamily function as transcription factors involved in innate and adaptive immunity as well as lipid metabolism. These highly conserved proteins participate in ligand-dependent or -independent regulatory mechanisms that affect gene expression. Peroxisome proliferator-activated receptors (PPARs), which include PPARα, PPARβ/δ, and PPARΓ, are a group of nuclear receptor proteins that play diverse roles in cellular differentiation, development, and metabolism. Each PPAR subfamily is activated by different endogenous and synthetic ligands. Recent studies using specific ligand treatments and cell type-specific PPAR knockout mice have revealed important roles for these proteins in T-cell-related autoimmune diseases. Moreover, PPARs have been shown to regulate T-cell survival, activation, and CD4+ T helper cell differentiation into the Th1, Th2, Th17, and Treg lineages. Here, we review the studies that provide insight into the important regulatory roles of PPARs in T-cell activation, survival, proliferation, differentiation, and autoimmune disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agostini, M., Schoenmakers, E., Mitchell, C., Szatmari, I., Savage, D., Smith, A., Rajanayagam, O., Semple, R., Luan, J., Bath, L., et al. (2006). Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell Metab. 4, 303–311.

    Article  PubMed  CAS  Google Scholar 

  • Akiyama, T.E., Baumann, C.T., Sakai, S., Hager, G.L., and Gonzalez, F.J. (2002). Selective intranuclear redistribution of PPAR isoforms by RXR alpha. Mol. Endocrinol. 16, 707–721.

    Article  PubMed  CAS  Google Scholar 

  • Azuma, Y.T., Nishiyama, K., Matsuo, Y., Kuwamura, M., Morioka, A., Nakajima, H., and Takeuchi, T. (2010). PPARalpha contributes to colonic protection in mice with DSS-induced colitis. Int. Immunopharmacol. 10, 1261–1267.

    Article  PubMed  CAS  Google Scholar 

  • Baratelli, F., Lin, Y., Zhu, L., Yang, S.C., Heuze-Vourc’h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., and Dubinett, S.M. (2005). Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175, 1483–1490.

    PubMed  CAS  Google Scholar 

  • Barish, G.D., Atkins, A.R., Downes, M., Olson, P., Chong, L.W., Nelson, M., Zou, Y., Hwang, H., Kang, H., Curtiss, L., et al. (2008). PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc. Natl. Acad. Sci. USA 105, 4271–4276.

    Article  PubMed  CAS  Google Scholar 

  • Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J., et al. (1999). Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883.

    PubMed  CAS  Google Scholar 

  • Berger, J., Leibowitz, M.D., Doebber, T.W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C.A., Hayes, N.S., Li, Y., et al. (1999). Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. 274, 6718–6725.

    Article  PubMed  CAS  Google Scholar 

  • Chan, M.M., Evans, K.W., Moore, A.R., and Fong, D. (2010). Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections. J. Biomed. Biotechnol. 2010, 828951.

    Article  PubMed  Google Scholar 

  • Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T.P., and Rastinejad, F. (2008). Structure of the intact PPAR-gamma-RXR-nuclear receptor complex on DNA. Nature 456, 350–356.

    Article  PubMed  Google Scholar 

  • Chawla, A., Repa, J.J., Evans, R.M., and Mangelsdorf, D.J. (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866–1870.

    Article  PubMed  CAS  Google Scholar 

  • Choi, J.M., Ahn, M.H., Chae, W.J., Jung, Y.G., Park, J.C., Song, H.M., Kim, Y.E., Shin, J.A., Park, C.S., Park, J.W., et al. (2006). Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat. Med. 12, 574–579.

    Article  PubMed  CAS  Google Scholar 

  • Choi, J.M., Shin, J.H., Sohn, M.H., Harding, M.J., Park, J.H., Tobiasova, Z., Kim, D.Y., Maher, S.E., Chae, W.J., Park, S.H., et al. (2010). Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc. Natl. Acad. Sci. USA 107, 18575–18580.

    Article  PubMed  CAS  Google Scholar 

  • Clark, R.B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., and Padula, S.J. (2000). The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. J. Immunol. 164, 1364–1371.

    PubMed  CAS  Google Scholar 

  • Daynes, R.A., and Jones, D.C. (2002). Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2, 748–759.

    Article  PubMed  CAS  Google Scholar 

  • Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J.M., Gonzalez, F.J., Fruchart, J.C., Tedgui, A., Haegeman, G., and Staels, B. (1999). Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274, 32048–32054.

    Article  PubMed  CAS  Google Scholar 

  • Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001). Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 193, 827–838.

    Article  PubMed  CAS  Google Scholar 

  • Dunn, S.E., Ousman, S.S., Sobel, R.A., Zuniga, L., Baranzini, S.E., Youssef, S., Crowell, A., Loh, J., Oksenberg, J., and Steinman, L. (2007). Peroxisome proliferator-activated receptor (PPAR) alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J. Exp. Med. 204, 321–330.

    Article  PubMed  CAS  Google Scholar 

  • Dunn, S.E., Bhat, R., Straus, D.S., Sobel, R.A., Axtell, R., Johnson, A., Nguyen, K., Mukundan, L., Moshkova, M., Dugas, J.C., et al. (2010) Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J. Exp. Med. 207, 1599–1608.

    Article  PubMed  CAS  Google Scholar 

  • Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A.M., Saladin, R., Najib, J., Laville, M., Fruchart, J.C., Deeb, S., et al. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem. 272, 18779–18789.

    Article  PubMed  CAS  Google Scholar 

  • Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B. M., and Evans, R.M. (1995). 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803–812.

    Article  PubMed  CAS  Google Scholar 

  • Forman, B.M., Chen, J., and Evans, R.M. (1997). Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA 94, 4312–4317.

    Article  PubMed  CAS  Google Scholar 

  • Gervois, P., Fruchart, J.C., and Staels, B. (2007). Drug Insight:mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nat. Clin. Pract. Endocrinol. Metab. 3, 145–156.

    Article  PubMed  CAS  Google Scholar 

  • Glass, C.K., and Ogawa, S. (2006). Combinatorial roles of nuclear receptors in inflammation and immunity. Nat. Rev. Immunol. 6, 44–55.

    Article  PubMed  CAS  Google Scholar 

  • Glass, C.K., and Saijo, K. (2010). Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 10, 365–376.

    Article  PubMed  CAS  Google Scholar 

  • Gocke, A.R., Hussain, R.Z., Yang, Y., Peng, H., Weiner, J., Ben, L.H., Drew, P.D., Stuve, O., Lovett-Racke, A.E., and Racke, M.K. (2009). Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease. J. Immunol. 182, 4479–4487.

    Article  PubMed  CAS  Google Scholar 

  • Gosset, P., Charbonnier, A.S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A.B., and Trottein, F. (2001). Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 31, 2857–2865.

    Article  PubMed  CAS  Google Scholar 

  • Guan, H.P., Ishizuka, T., Chui, P.C., Lehrke, M., and Lazar, M.A. (2005). Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 19, 453–461.

    Article  PubMed  CAS  Google Scholar 

  • Guri, A.J., Mohapatra, S.K., Horne, W.T., 2nd, Hontecillas, R., and Bassaganya-Riera, J. (2010). The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease. BMC Gastroenterol. 10, 60.

    Article  PubMed  Google Scholar 

  • Harris, S.G., and Phipps, R.P. (2001). The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur. J. Immunol. 31, 1098–1105.

    Article  PubMed  CAS  Google Scholar 

  • Hegele, R.A., Cao, H., Frankowski, C., Mathews, S.T., and Leff, T. (2002). PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51, 3586–3590.

    Article  PubMed  CAS  Google Scholar 

  • Hontecillas, R., and Bassaganya-Riera, J. (2007). Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J. Immunol. 178, 2940–2949.

    PubMed  CAS  Google Scholar 

  • Housley, W.J., Adams, C.O., Vang, A.G., Brocke, S., Nichols, F.C., LaCombe, M., Rajan, T.V., and Clark, R.B. (2011). Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity. J. Immunol. 187, 4161–4169.

    Article  PubMed  CAS  Google Scholar 

  • Itoh, T., Fairall, L., Amin, K., Inaba, Y., Szanto, A., Balint, B.L., Nagy, L., Yamamoto, K., and Schwabe, J.W. (2008). Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 15, 924–931.

    Article  PubMed  CAS  Google Scholar 

  • Jiang, C., Ting, A.T., and Seed, B. (1998). PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86.

    Article  PubMed  CAS  Google Scholar 

  • Jo, S.H., Yang, C., Miao, Q., Marzec, M., Wasik, M.A., Lu, P., and Wang, Y.L. (2006). Peroxisome proliferator-activated receptor gamma promotes lymphocyte survival through its actions on cellular metabolic activities. J. Immunol. 177, 3737–3745.

    PubMed  CAS  Google Scholar 

  • Jones, D.C., Ding, X., and Daynes, R.A. (2002). Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J. Biol. Chem. 277, 6838–6845.

    Article  PubMed  CAS  Google Scholar 

  • Kanakasabai, S., Chearwae, W., Walline, C.C., Iams, W., Adams, S.M., and Bright, J.J. (2010). Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis. Immunology 130, 572–588.

    Article  PubMed  CAS  Google Scholar 

  • Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K., and Evans, R.M. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355–7359.

    Article  PubMed  CAS  Google Scholar 

  • Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S., Devchand, P., Wahli, W., Willson, T.M., Lenhard, J.M., et al. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 94, 4318–4323.

    Article  PubMed  CAS  Google Scholar 

  • Klotz, L., Dani, I., Edenhofer, F., Nolden, L., Evert, B., Paul, B., Kolanus, W., Klockgether, T., Knolle, P., and Diehl, L. (2007). Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. J. Immunol. 178, 2122–2131.

    PubMed  CAS  Google Scholar 

  • Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., Alferink, J., Nowak, N., Beyer, M., Mayer, G., et al. (2009). The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206, 2079–2089.

    Article  PubMed  CAS  Google Scholar 

  • Lee, J.W., Bajwa, P.J., Carson, M.J., Jeske, D.R., Cong, Y., Elson, C.O., Lytle, C., and Straus, D.S. (2007). Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133, 108–123.

    Article  PubMed  CAS  Google Scholar 

  • Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferatoractivated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953–12956.

    Article  PubMed  CAS  Google Scholar 

  • Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835–839.

    Article  PubMed  CAS  Google Scholar 

  • McKenna, N.J., and O’Malley, B.W. (2002). Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465–474.

    Article  PubMed  CAS  Google Scholar 

  • Moras, D., and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384–391.

    Article  PubMed  CAS  Google Scholar 

  • Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R.K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M.G., et al. (2005). Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707–721.

    Article  PubMed  CAS  Google Scholar 

  • Oliver, W.R., Jr., Shenk, J.L., Snaith, M.R., Russell, C.S., Plunket, K.D., Bodkin, N.L., Lewis, M.C., Winegar, D.A., Sznaidman, M. L., Lambert, M.H., et al. (2001). A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98, 5306–5311.

    Article  PubMed  CAS  Google Scholar 

  • Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Willson, T.M., Rosenfeld, M.G., and Glass, C.K. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759–763.

    Article  PubMed  CAS  Google Scholar 

  • Peraza, M.A., Burdick, A.D., Marin, H.E., Gonzalez, F.J., and Peters, J.M. (2006). The toxicology of ligands for peroxisome pro-liferator-activated receptors (PPAR). Toxicol. Sci. 90, 269–295.

    Article  PubMed  CAS  Google Scholar 

  • Polak, P.E., Kalinin, S., Dello Russo, C., Gavrilyuk, V., Sharp, A., Peters, J.M., Richardson, J., Willson, T.M., Weinberg, G., and Feinstein, D.L. (2005). Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 168, 65–75.

    Article  PubMed  CAS  Google Scholar 

  • Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D. (1995). Crystal structure of the RARgamma ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681–689.

    Article  PubMed  CAS  Google Scholar 

  • Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79–82.

    Article  PubMed  CAS  Google Scholar 

  • Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., and Kahn, C.R. (1998). Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339, 953–959.

    Article  PubMed  CAS  Google Scholar 

  • Sanderson, L.M., Degenhardt, T., Koppen, A., Kalkhoven, E., Desvergne, B., Muller, M., and Kersten, S. (2009). Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. Mol. Cell. Biol. 29, 6257–6267.

    Article  PubMed  CAS  Google Scholar 

  • Setoguchi, K., Misaki, Y., Terauchi, Y., Yamauchi, T., Kawahata, K., Kadowaki, T., and Yamamoto, K. (2001). Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J. Clin. Invest. 108, 1667–1675.

    PubMed  CAS  Google Scholar 

  • Su, C.G., Wen, X., Bailey, S.T., Jiang, W., Rangwala, S.M., Keilbaugh, S.A., Flanigan, A., Murthy, S., Lazar, M.A., and Wu, G.D. (1999a). A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104, 383–389.

    Article  PubMed  CAS  Google Scholar 

  • Su, J.L., Winegar, D.A., Wisely, G.B., Sigel, C.S., and Hull-Ryde, E.A. (1999b). Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro. Hybridoma 18, 273–280.

    Article  PubMed  CAS  Google Scholar 

  • Szanto, A., Balint, B.L., Nagy, Z.S., Barta, E., Dezso, B., Pap, A., Szeles, L., Poliska, S., Oros, M., Evans, R.M., et al. (2010). STAT6 transcription factor is a facilitator of the nuclear receptor PPARgamma-regulated gene expression in macrophages and dendritic cells. Immunity 33, 699–712.

    Article  PubMed  CAS  Google Scholar 

  • Szatmari, I., Pap, A., Ruhl, R., Ma, J.X., Illarionov, P.A., Besra, G.S., Rajnavolgyi, E., Dezso, B., and Nagy, L. (2006). PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203, 2351–2362.

    Article  PubMed  CAS  Google Scholar 

  • Szatmari, I., Torocsik, D., Agostini, M., Nagy, T., Gurnell, M., Barta, E., Chatterjee, K., and Nagy, L. (2007). PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110, 3271–3280.

    Article  PubMed  CAS  Google Scholar 

  • Takata, Y., Liu, J., Yin, F., Collins, A.R., Lyon, C.J., Lee, C.H., Atkins, A.R., Downes, M., Barish, G.D., Evans, R.M., et al. (2008). PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc. Natl. Acad. Sci. USA 105, 4277–4282.

    Article  PubMed  CAS  Google Scholar 

  • Tobiasova, Z., Zhang, L., Yi, T., Qin, L., Manes, T.D., Kulkarni, S., Lorber, M.I., Rodriguez, F.C., Choi, J.M., Tellides, G., et al. (2011). Peroxisome proliferator-activated receptor-gamma agonists prevent in vivo remodeling of human artery induced by alloreactive T cells. Circulation 124, 196–205.

    Article  PubMed  CAS  Google Scholar 

  • Varga, T., Czimmerer, Z., and Nagy, L. (2011). PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim. Biophys. Acta 1812, 1007–1022.

    PubMed  CAS  Google Scholar 

  • Wang, Y.L., Frauwirth, K.A., Rangwala, S.M., Lazar, M.A., and Thompson, C.B. (2002). Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. J. Biol. Chem. 277, 31781–31788.

    Article  PubMed  CAS  Google Scholar 

  • Wohlfert, E.A., Nichols, F.C., Nevius, E., and Clark, R.B. (2007). Peroxisome proliferator-activated receptor gamma (PPAR gamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J. Immunol. 178, 4129–4135.

    PubMed  CAS  Google Scholar 

  • Yang, X.Y., Wang, L.H., Chen, T., Hodge, D.R., Resau, J.H., Da Silva, L., and Farrar, W.L. (2000). Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J. Biol. Chem. 275, 4541–4544.

    CAS  Google Scholar 

  • Yang, Y., Lovett-Racke, A.E., and Racke, M.K. (2010). Regulation of immune responses and autoimmune encephalomyelitis by PPARs. PPAR Res. 2010, 104705.

    Article  PubMed  Google Scholar 

  • Zieleniak, A., Wojcik, M., and Wozniak, L.A. (2008). Structure and physiological functions of the human peroxisome proliferatoractivated receptor gamma. Arch. Immunol. Ther. Exp. (Warsz) 56, 331–345.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Life Science, Research Institute for Natural Sciences, Hanyang Universtiy, Seoul, 133-791, Korea

    Je-Min Choi

  2. Hanyang Biomedical Research Institute, Hanyang Universtiy, Seoul, 133-791, Korea

    Je-Min Choi

  3. Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA

    Alfred L. M. Bothwell

Authors
  1. Je-Min Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfred L. M. Bothwell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Je-Min Choi or Alfred L. M. Bothwell.

About this article

Cite this article

Choi, JM., Bothwell, A.L.M. The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases. Mol Cells 33, 217–222 (2012). https://doi.org/10.1007/s10059-012-2297-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10059-012-2297-y

Keywords

Search

Navigation